RXQ Compounding LLC FDA Inspection Record
RXQ Compounding LLC is an FDA-inspected facility (FEI 3011509553) located in Albany, OH, US. RegDataLab tracks 2 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Aug 8, 2017: Official Action Indicated (OAI)
- Inspections on record
- 2 (2 OAI)
- Last OAI inspection
- Aug 8, 2017
- Warning letters
- 1 listed by FDA for this FEI, latest May 19, 2016
- Form 483 and inspection documents
- 3 in FDA's reading room
- Recalls as the recalling firm
- 3, latest Jun 19, 2019
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Aug 8, 2017 | Official Action Indicated (OAI) | Inadequate number of personnel (21 CFR 211.25(c)) SOPs not followed / documented (21 CFR 211.100(b)) Environmental Monitoring System (21 CFR 211.42(c)(10)(iv)) Cleaning System (21 CFR 211.42(c)(10)(v)) and 5 more |
| Sep 21, 2015 | Official Action Indicated (OAI) | Clothing appropriate for duties performed (21 CFR 211.28(a)) Air Supply (21 CFR 211.42(c)(10)(iii)) Environmental Monitoring System (21 CFR 211.42(c)(10)(iv)) Validation lacking for sterile drug products (21 CFR 211.113(b)) and 5 more |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Jun 19, 2019 | Class II | D-1634-2019 | Ascorbic Acid 500 MG/ML (Non-Corn) Injection (PFV), 50 mL per vial, RXQ Compounding, 340… and 85 more products Crystallization |
| Sep 25, 2018 | Class II | D-0130-2019 | Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340… Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent. |
| Sep 25, 2017 | Class II | D-0012-2018 | methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding… Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product. |
Form 483s and inspection documents
FDA record score
11 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
6 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified OAI | Aug 8, 2017 | 30 x 0.25 | 7.5 |
| Class II recall D-1634-2019, this FEI as the recalling firm | Jun 19, 2019 | 4 x 0.25 | 1 |
| Class II recall D-0130-2019, this FEI as the recalling firm | Sep 25, 2018 | 4 x 0.25 | 1 |
| Class II recall D-0012-2018, this FEI as the recalling firm | Sep 25, 2017 | 4 x 0.25 | 1 |
| Warning letter on FDA's dashboard, which does not show close-outs | May 19, 2016 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Sep 21, 2015 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 22, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
| Warning letter text | Nov 22, 2026 | Newest record Nov 17, 2026 | Current |
| Recalls (Enforcement Report) | Nov 22, 2026 | Newest record Nov 18, 2026 | Current |
| Form 483s and inspection documents | Nov 18, 2026 | Newest record Nov 17, 2026 | Current |
| Import refusals | Nov 22, 2026 | Newest record Nov 12, 2026 | Current |
Reviewing RXQ Compounding LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check RXQ Compounding LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- RXQ Compounding LLC
- Location
- Albany, OH (US)
- Source
- inspections